-
article
Laprise JF, Chesson HW, Markowitz LE, Drolet M, Brisson M
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the Uni…
Ann Intern Med
178 (1), 2025.
-
article
Middeldorp M, Donken R, Nirmal A, Smith B, Citlali Marquez A, Bettinger JA, Brisson M, Burchell AN, Dobson SR, Dawar M, Franco EL, Grennan T, Krajden M, Mayrand MH, McNeil S, Naus M, Sauvageau C, Singer J, Smith LW, Ogilvie GS, Sadarangani M
Quadrivalent HPV Vaccine Evaluation Study with Addition of the Nonavalent Vaccine (QUEST-ADVANCE): protocol of an observational cohort study
BMJ Open
15 (9), 2025.
-
article
Laprise JF, Chesson HW, Markowitz LE, Drolet M, Brisson M
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the Unit…
Ann Intern Med
178 (11), 2025.
-
article
Bénard É and Drolet M, Gingras G, Laprise JF, Sabourin AA, Bloem P, Akaba H, Brotherton J, Jit M, Brisson M
Ranking the most efficient human papillomavirus vaccination strategies in low-income and lower-middle income countries: a mathematical modelling analysis
Lancet Glob Health
13 (12), 2025.
-
article
Wright J, Crowcroft N, McLachlan E, Perez-Iratxeta C, Joh E, Osman S, Hatchette T, Deeks SL, Wilson SE, Hughes SL, Halperin SA, Buchan SA, Ward BJ, Gubbay J, Brisson M, Serhir B, Severini A, Bolotin S
Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) study
PLoS One
19 (8), 2024.
-
article
Prem K, Cernuschi T, Malvolti S, Brisson M, Jit M
Optimal human papillomavirus vaccination strategies in the context of vaccine supply constraints in 100 countries
EClinicalMedicine
74 2024.
-
article
Whitworth HS, Mounier-Jack S, Choi EM, Gallagher KE, Howard N, Kelly H, Mbwanji G, Kreimer AR, Basu P, Barnabas R, Drolet M, Brisson M, Watson-Jones D
Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of eviden…
Vaccine X
19 2024.
-
article
Burger EA, Laprise JF, Portnoy A, Spencer JC, Sy S, Regan MC, Bénard É and Drolet M, Brisson M, Kim JJ
Population-level health impact of hypothetical waning 1-dose human papillomavirus vaccination and 2-dose mitigation strategies in a high cervical cancer burden setting
J Natl Cancer Inst Monogr
2024 (67), 2024.
-
article
Brisson M, Laprise JF, Drolet M, Chamberland É and Bénard É and Burger EA, Jit M, Kim JJ, Markowitz LE, Sauvageau C, Sy S
Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modeling
J Natl Cancer Inst Monogr
2024 (67), 2024.
-
article
Drolet M, Laprise JF, Chamberland É and Sauvageau C, Wilson S, Lim GH, Ogilvie G, Tuite A, Brisson M
Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis
CMAJ
196 (33), 2024.
-
article
Yokoji K, Giguère K, Malagón T, Rönn MM, Mayaud P, Kelly H, Delany-Moretlwe S, Drolet M, Brisson M, Boily MC, Maheu-Giroux M
Association of naturally acquired type-specific HPV antibodies and subsequent HPV re-detection: systematic review and meta-analysis
Infect Agent Cancer
18 (1), 2023.
-
article
Anato JLF, Ma H, Hamilton MA, Xia Y, Harper S, Buckeridge D, Brisson M, Hillmer MP, Malikov K, Kerem A, Beall R, Wagner CE, Racine É and Baral S, Dubé È and Mishra S, Maheu-Giroux M
Impact of a vaccine passport on first-dose SARS-CoV-2 vaccine coverage by age and area-level social determinants of health in the Canadian provinces of Quebec and Ontario: an in…
CMAJ Open
11 (5), 2023.